Review decisions

Showing 60 results of 281 total
Summary Safety Review - Sofosbuvir-containing products - Assessing the Potential Risk of Severe Cutaneous Adverse Reactions
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00256
Issued / Original Publication Date: 2021-01-27
Summary Safety Review - Tamiflu (oseltamivir) and generics - Assessing the Potential Risk of Haemorrhages
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00255
Issued / Original Publication Date: 2021-01-08
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Trea™ent Discontinuation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00254
Issued / Original Publication Date: 2021-01-06
Summary Safety Review - Tramadol-containing products - Assessing the Potential Risk of Hallucinations
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00253
Issued / Original Publication Date: 2020-12-29
Summary Safety Review - Carboplatin-containing products - Assessing the Potential Risk of Posterior Reversible Encephalopathy Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00252
Issued / Original Publication Date: 2020-12-16
Summary Safety Review - Clobazam-containing products - Assessing the Potential Risk of Drug Reaction with Eosinophilia and Systemic Symptoms
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00251
Issued / Original Publication Date: 2020-12-09
Summary Safety Review - Direct-acting antiviral products containing a Protease Inhibitor - Assessing the Potential Risks of Hepatic Decompensation and Hepatic Failure
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00249
Issued / Original Publication Date: 2020-12-02
Summary Safety Review - Bacitracin for Injection Products - Assessing the Potential Risks of Nephrotoxicity and Anaphylactic Reactions
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00250
Issued / Original Publication Date: 2020-12-02
Summary Safety Review - Brilinta (ticagrelor) - Assessing the Potential Risk of Central Sleep Apnea
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00248
Issued / Original Publication Date: 2020-10-28
Summary Safety Review - Mesalazine-containing products - Assessing the Potential Risk of Birth Defects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00247
Issued / Original Publication Date: 2020-09-24

Displaying 51 - 60 of 281 | Page 6 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: